Fintel reports that on October 7, 2025, Citigroup maintained coverage of Haemonetics (NYSE:HAE) with a Buy recommendation.
Analyst Price Forecast Suggests 66.34% Upside
As of September 29, 2025, the average one-year price target for Haemonetics is $81.91/share. The forecasts range from a low of $58.58 to a high of $113.40. The average price target represents an increase of 66.34% from its latest reported closing price of $49.24 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Haemonetics is 1,270MM, a decrease of 5.65%. The projected annual non-GAAP EPS is 4.41.
What is the Fund Sentiment?
There are 690 funds or institutions reporting positions in Haemonetics. This is an decrease of 42 owner(s) or 5.74% in the last quarter. Average portfolio weight of all funds dedicated to HAE is 0.23%, an increase of 2.18%. Total shares owned by institutions decreased in the last three months by 4.73% to 71,186K shares. 
The put/call ratio of HAE is 0.73, indicating a bullish outlook.
What are Other Shareholders Doing?
Neuberger Berman Group holds 4,277K shares representing 8.88% ownership of the company. In its prior filing, the firm reported owning 4,348K shares , representing a decrease of 1.66%. The firm increased its portfolio allocation in HAE by 6.09% over the last quarter.
NBGNX - Neuberger Berman Genesis Fund Investor Class holds 2,160K shares representing 4.48% ownership of the company. In its prior filing, the firm reported owning 2,214K shares , representing a decrease of 2.53%. The firm increased its portfolio allocation in HAE by 8.28% over the last quarter.
Wellington Management Group Llp holds 2,146K shares representing 4.45% ownership of the company. In its prior filing, the firm reported owning 2,625K shares , representing a decrease of 22.30%. The firm decreased its portfolio allocation in HAE by 87.29% over the last quarter.
River Road Asset Management holds 1,656K shares representing 3.44% ownership of the company. In its prior filing, the firm reported owning 1,395K shares , representing an increase of 15.74%. The firm increased its portfolio allocation in HAE by 29.11% over the last quarter.
IJH - iShares Core S&P Mid-Cap ETF holds 1,636K shares representing 3.40% ownership of the company. In its prior filing, the firm reported owning 1,638K shares , representing a decrease of 0.09%. The firm increased its portfolio allocation in HAE by 10.58% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
